Device Endovive_endo

Endovive Low Profile Replacement Button

Payments companies reported to CMS as associated with Endovive Low Profile Replacement Button. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$1,682associated payments (2023-2025)
40clinicians with associated payments
1company reporting

By year

2023 $103
2024 $1,534
2025 $44.62

Payments reported as associated with Endovive Low Profile Replacement Button, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Gastroenterology (Internal Medicine) $968
Internal Medicine $231
Nurse Practitioner $13.29
Thoracic Surgery (Cardiothoracic Vascular Surgery) $13.29

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Endovive Low Profile Replacement Button

These are the largest totals companies reported as associated with Endovive Low Profile Replacement Button. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Jose Aponte Pieras Las Vegas, NV Gastroenterology (Internal Medicine) $67.96
Gordon Ohning Las Vegas, NV Gastroenterology (Internal Medicine) $67.96
Scott Diamond St George, UT Gastroenterology (Internal Medicine) $67.95
Youssef Ghobrial Las Vegas, NV Internal Medicine $67.95
Abdul Gader Gheriani Las Vegas, NV Gastroenterology (Internal Medicine) $67.95
Shruthi Narasimha Riverview, FL Gastroenterology (Internal Medicine) $67.95
John Ryan Las Vegas, NV Gastroenterology (Internal Medicine) $67.95
Keaton Maguire Las Vegas, NV Internal Medicine $67.95
Vignan Manne Las Vegas, NV Gastroenterology (Internal Medicine) $67.95
Preet Patel Las Vegas, NV $67.95

Prescribed Endovive Low Profile Replacement Button?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.